Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Novartis
Ascentage Pharma Group Inc.
Astex Pharmaceuticals, Inc.
Takeda
Xencor, Inc.
Incyte Corporation
Novartis
Novartis
Takeda
Eli Lilly and Company
Novartis
Tragara Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Teva Branded Pharmaceutical Products R&D, Inc.
Cellerant Therapeutics
Synta Pharmaceuticals Corp.
INSYS Therapeutics Inc
Millennium Pharmaceuticals, Inc.
Novartis
Novartis
Daiichi Sankyo
Novartis
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb